These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33812220)

  • 1. Development and validation of the Benzodiazepine Hypnotics Withdrawal Symptom Scale (BHWSS) based on item response theory.
    Narisawa H; Inoue Y; Kobayashi M; Okajima I; Kikuchi T; Kagimura T; Matsui K; Inada K; Mishima K
    Psychiatry Res; 2021 Jun; 300():113900. PubMed ID: 33812220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study.
    Inoue Y; Takaesu Y; Koebis M
    BMC Psychiatry; 2021 Apr; 21(1):193. PubMed ID: 33853571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life.
    Curran HV; Collins R; Fletcher S; Kee SC; Woods B; Iliffe S
    Psychol Med; 2003 Oct; 33(7):1223-37. PubMed ID: 14580077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin and melatonin agonists as treatments for benzodiazepines and hypnotics withdrawal in patients with primary insomnia. A systematic review.
    Morera-Fumero AL; Fernandez-Lopez L; Abreu-Gonzalez P
    Drug Alcohol Depend; 2020 Jul; 212():107994. PubMed ID: 32409111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected].
    Davies J; Rae TC; Montagu L
    Br J Gen Pract; 2017 Sep; 67(662):e609-e613. PubMed ID: 28716996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine tapering: a prospective study.
    Vikander B; Koechling UM; Borg S; Tönne U; Hiltunen AJ
    Nord J Psychiatry; 2010 Aug; 64(4):273-82. PubMed ID: 20629611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic benzodiazepine usage and withdrawal in insomnia patients.
    Poyares D; Guilleminault C; Ohayon MM; Tufik S
    J Psychiatr Res; 2004; 38(3):327-34. PubMed ID: 15003439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiety or depression during withdrawal of hypnotic treatments.
    Lader M
    J Psychosom Res; 1994; 38 Suppl 1():113-23; discussion 118-23. PubMed ID: 7799243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal?
    Poyares DR; Guilleminault C; Ohayon MM; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):539-45. PubMed ID: 11999905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and associated factors of hypnotics dependence among Japanese outpatients with psychiatric disorders.
    Murakoshi A; Takaesu Y; Komada Y; Ishikawa J; Inoue Y
    Psychiatry Res; 2015 Dec; 230(3):958-63. PubMed ID: 26614012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study.
    Bourgeois J; Elseviers MM; Van Bortel L; Petrovic M; Vander Stichele RH
    Eur J Clin Pharmacol; 2014 Oct; 70(10):1251-60. PubMed ID: 25098683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.
    Stein MD; Kanabar M; Anderson BJ; Lembke A; Bailey GL
    J Subst Abuse Treat; 2016 Sep; 68():57-61. PubMed ID: 27431047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits associated with switching from benzodiazepine hypnotics to suvorexant in patients with mild primary insomnia.
    Suzuki H; Hibino H; Inoue Y; Mikami A; Matsumoto H; Mikami K
    Asian J Psychiatr; 2017 Oct; 29():71-72. PubMed ID: 29061431
    [No Abstract]   [Full Text] [Related]  

  • 15. Development and acceptability of a decision aid for chronic insomnia considering discontinuation of benzodiazepine hypnotics.
    Aoki Y; Takaesu Y; Suzuki M; Okajima I; Takeshima M; Shimura A; Utsumi T; Kotorii N; Yamashita H; Kuriyama K; Watanabe N; Mishima K
    Neuropsychopharmacol Rep; 2022 Mar; 42(1):10-20. PubMed ID: 34807524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current state of hypnotic use disorders: Results of a survey using the Japanese version of Benzodiazepine Dependence Self-Report Questionnaire.
    Yamamoto M; Inada K; Enomoto M; Habukawa M; Hirose T; Inoue Y; Ishigooka J; Kamei Y; Kitajima T; Miyamoto M; Shinno H; Nishimura K; Ozone M; Takeshima M; Suzuki M; Yamashita H; Mishima K
    Neuropsychopharmacol Rep; 2021 Mar; 41(1):14-25. PubMed ID: 33259705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxation to assist sleep medication withdrawal.
    Lichstein KL; Peterson BA; Riedel BW; Means MK; Epperson MT; Aguillard RN
    Behav Modif; 1999 Jul; 23(3):379-402. PubMed ID: 10467890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with long-term use of hypnotics among patients with chronic insomnia.
    Takaesu Y; Komada Y; Asaoka S; Kagimura T; Inoue Y
    PLoS One; 2014; 9(11):e113753. PubMed ID: 25409018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: A systematic review and meta-analysis.
    Takaesu Y; Utsumi T; Okajima I; Shimura A; Kotorii N; Kuriyama K; Yamashita H; Suzuki M; Watanabe N; Mishima K
    Sleep Med Rev; 2019 Dec; 48():101214. PubMed ID: 31648145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients?
    Jobert A; Laforgue EJ; Grall-Bronnec M; Rousselet M; Péré M; Jolliet P; ; Feuillet F; Victorri-Vigneau C
    Eur J Clin Pharmacol; 2021 Feb; 77(2):171-177. PubMed ID: 33006626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.